Advisory Services Network’s Purple Biotech PPBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-9
Closed -$36 3990
2026
Q1
$36 Buy
+9
New +$49 ﹤0.01% 4778
2025
Q4
Sell
-10
Closed -$57 3620
2025
Q3
$57 Buy
+10
New +$179 ﹤0.01% 4458
2024
Q1
Sell
-10
Closed -$1.56K 3086
2023
Q4
$1.56K Buy
+10
New +$2.21K ﹤0.01% 3455
2023
Q2
Sell
-10
Closed -$3.57K 3068
2023
Q1
$3.57K Hold
10
﹤0.01% 3258
2022
Q4
$2.75K Buy
+10
New +$3.84K ﹤0.01% 3320
2021
Q3
Sell
-10
Closed -$9K 2749
2021
Q2
$9K Buy
+10
New +$9.18K ﹤0.01% 2865
2021
Q1
Sell
-10
Closed -$7K 2528
2020
Q4
$7K Hold
10
﹤0.01% 2602
2020
Q3
$9K Hold
10
﹤0.01% 2505
2020
Q2
$22K Buy
10
+5
+100% +$4.91K ﹤0.01% 1038
2020
Q1
$3K Hold
5
﹤0.01% 2662
2019
Q4
$8K Buy
5
+4
+400% +$5.84K ﹤0.01% 2455
2019
Q3
$1K Hold
1
﹤0.01% 2731
2019
Q2
$1K Hold
1
﹤0.01% 2729
2019
Q1
$2K Buy
+1
New +$2.41K ﹤0.01% 2346

Other funds holding PPBT

Advisory Services Network's PPBT Position: Q2 2026 in Review

Advisory Services Network sold out of Purple Biotech (PPBT) in Q2 2026, closing a stake of 9 shares — an estimated $36 sold.

Advisory Services Network first reported a position in PPBT in Q1 2019 and held it in 14 quarters. The position peaked at $22K in Q2 2020. 13 funds tracked by Wall St. Rank hold PPBT as of Q2 2026.

  • Advisory Services Network reported no remaining Purple Biotech position as of Q2 2026 after selling out during the quarter.
  • Advisory Services Network sold 9 Purple Biotech shares in Q2 2026, an estimated $36.
  • Advisory Services Network first reported a position in Purple Biotech in Q1 2019 and held it in 14 quarters.
  • Advisory Services Network's Purple Biotech position peaked at $22K in Q2 2020.
  • 13 funds tracked by Wall St. Rank held Purple Biotech as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.